cadonilimab
Akeso’s Cadonilimab Achieves Significant Overall Survival in Severe Gastric Cancer Patients
Anika Sharma
Akeso’s bispecific antibody has demonstrated a significant improvement in overall survival for first-line patients with severe gastric cancer or gastroesophageal ...
